Medical Doctor Program year 2019 Source: CMS Open Payments, 2026 publication

William Cook

MOHS-Micrographic Surgery Charleston, SC Medical Doctor

NPI 1639100100 CMS profile 119405

171 Ashley Ave, Charleston, SC 29425

Open in the dashboard

General payments

$23

1 record reported · program year 2019

Research payments

$0

Paid to them · None reported · program year 2019

Ownership & investment interest

$0

None reported

Through program year 2019, William Cook of Charleston, SC is reported in the CMS Open Payments database as having received $23 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 1st percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2019 General $23 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Cook
  • MOHS-Micrographic Surgery median
  • Middle half of MOHS-Micrographic Surgery
  • National median

In program year 2025, general payments to William Cook were reported at $0. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.

Show as a table
Year William Cook MOHS-Micrographic Surgery median Middle half National median
2019 $23 $316 $106–$785 $163
2020 $0 $162 $68–$412 $114
2021 $0 $243 $87–$654 $132
2022 $0 $300 $102–$887 $149
2023 $0 $364 $125–$1,010 $160
2024 $0 $445 $142–$1,108 $164
2025 $0 $465 $145–$1,066 $169

Breakdown

Who paid General payments · program year 2019
  1. Novo Nordisk Inc $23 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Food and Beverage $23 1 payment
Products named General payments · program year 2019
  1. Tresiba $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

1,171

Median for Micrographic Dermatologic Surgery: 314

Drug cost

$7,320

Median for Micrographic Dermatologic Surgery: $3,836

Branded share of claims

0%

Median for Micrographic Dermatologic Surgery: 1.2%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Timolol Maleate Generic 107 $1,982
Cephalexin Generic 433 $1,620
Doxycycline Hyclate Generic 243 $1,505
Clindamycin Hcl Generic 173 $1,047
Ciprofloxacin Hcl Generic 133 $463
Gentamicin Sulfate Generic 11 $325
Mupirocin Generic 42 $321
Oxycodone Hcl Generic 17 $43
Tramadol Hcl Generic 12 $12

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 366 Part D prescribers listed as Micrographic Dermatologic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 112 billing codes

Paid by Medicare

$2,177,273

Of which drugs: $1,195

Medicare patients

2,120

Average age 76

Services billed

11,945

952 women, 1,168 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 46%
Ischemic heart disease 25%
Diabetes 21%
Atrial fibrillation 20%
Cancer 19%
Chronic kidney disease 18%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 224 310 $223
Injection, fluorouracil, 500 mg J9190 Office 16 25 $57
Injection, ketorolac tromethamine, per 15 mg J1885 Office 16 32 $17

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other MOHS-Micrographic Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record